Show simple item record

dc.contributor.authorPriebe, S
dc.contributor.authorKelley, L
dc.contributor.authorOmer, S
dc.contributor.authorGolden, E
dc.contributor.authorWalsh, S
dc.contributor.authorKhanom, H
dc.contributor.authorKingdon, D
dc.contributor.authorRutterford, C
dc.contributor.authorMcCrone, P
dc.contributor.authorMcCabe, Rose
dc.date.accessioned2016-02-19T14:14:55Z
dc.date.issued2015
dc.description.abstractBACKGROUND: DIALOG+ was developed as a computer-mediated intervention, consisting of a structured assessment of patients' concerns combined with a solution-focused approach to initiate change. This study tested the effectiveness of DIALOG+ in the community treatment of patients with psychosis. METHOD: This was a pragmatic, exploratory, parallel-group, cluster-randomised controlled trial. Clinicians within community teams - along with patients with psychosis under their care - were randomised to use DIALOG+ once per month for 6 months or an active control. The primary outcome (subjective quality of life, SQOL) and secondary outcomes were assessed after 3, 6 and 12 months by blinded assessors and analysed using mixed-effect models. RESULTS: A total of 49 clinicians and 179 patients were randomised. Implementation of DIALOG+ was variable, with an average of 1.8 sessions (SD = 1.6) in the first 3 months and 1.1 (SD = 1.2) in the following 3 months. Patients in the DIALOG+ arm had better SQOL at 3, 6 and 12 months (p = 0.035, 0.058 and 0.014, respectively; Cohen's d = 0.29-0.34). They also had significantly fewer unmet needs at 3 and 6 months, fewer general psychopathological symptoms at all time points and better objective social outcomes at 12 months, with no significant differences in other outcomes. Overall care costs were lower in the intervention group. CONCLUSION: Despite variable implementation, DIALOG+ is a beneficial intervention for community patients with psychosis. As a non-expensive and potentially cost-saving, generic intervention, DIALOG+ may be widely used and may improve the effectiveness of community treatment. Further trials should test DIALOG+ in different patient groups and contexts.en_GB
dc.description.sponsorshipNational Institute for Health Research (NIHR)en_GB
dc.identifier.citationVol. 84, pp. 304 - 313en_GB
dc.identifier.doi10.1159/000430991
dc.identifier.grantnumberRP-PG- 0108-10023en_GB
dc.identifier.other000430991
dc.identifier.urihttp://hdl.handle.net/10871/19973
dc.language.isoenen_GB
dc.publisherKargeren_GB
dc.relation.urlhttp://www.ncbi.nlm.nih.gov/pubmed/26278784en_GB
dc.rightsThis is an Open Access article licensed under the terms of the Creative Commons Attribution-NonCommercial 3.0 Unported license (CC BY-NC) (www.karger.com/OA-license), applicable to the online version of the article only. Distribution permitted for non-commercial purposes onlyen_GB
dc.subjectcomputer mediationen_GB
dc.subjectpsychiatric treatmenten_GB
dc.subjectquality of lifeen_GB
dc.subjectSchizophreniaen_GB
dc.subjecttreatment outcomesen_GB
dc.titleThe effectiveness of a patient-centred assessment with a solution-focused approach (DIALOG+) for patients with ssychosis: A pragmatic cluster-randomised controlled trial in community careen_GB
dc.typeArticleen_GB
dc.date.available2016-02-19T14:14:55Z
dc.identifier.issn0033-3190,
exeter.place-of-publicationSwitzerland
dc.descriptionAuthor's manuscript version. This is an open access article and the final published version is available via DOI:10.1159/000430991. © 2015 S. Karger AG, Baselen_GB
dc.identifier.journalPsychotherapy and Psychosomaticsen_GB
dc.identifier.pmid26278784


Files in this item

This item appears in the following Collection(s)

Show simple item record